| abstract |
FIELD: biochemistry.SUBSTANCE: invention relates to compounds of Formula (I) or their pharmacologically acceptable salts, which destroy, inhibit or prevent the growth or spread into the surrounding tissues of cells, especially malignant cells involved in various diseases of humans and animals. A compound of formula (I) or its pharmacologically acceptable salt is proposed, where R1and R5are in each case independently selected from hydrogen, C1-C10alkyl group; R2is selected from hydrogen and C1-C10alkyl group, optionally substituted with one or more-OR group, and C1-C10alkoxy group, optionally substituted with one or more-OR group, while R is selected from hydrogen and C1-C10alkyl group; R3means hydrogen; R4is selected from C1-C10alkyl group. a group, optionally replaced by one or more groups selected from -NRR' and -ОR groups, С1-С10alkoxy group, optionally substituted by one or more groups selected from -NRR' and -ОR groups, and -CONRR', while R and R' are independently selected from hydrogen in each case, С1-С10alkyl group, optionally substituted by one or more groups selected from OH, NH2, NHCOH and the water solubilizing group; A means a heterocyclic group selected from triazolyl, oxotriazolyl, imidazolyl, oxoimidazolidinyl, pyrazolyl, pyridyl, oxopyridyl, thiazolyl, and oxopyrrolidinyl, optionally substituted by one or more groups selected fromС1-С10alkyl, С1-С10alkoxy, -С1-С10alkyl-NRR', -С1-С10alkyl-NR-CO-R', wherein R and R' are in each case independently selected from hydrogen, С1-С10alkyl groups; В means a five-membered heteroaryl group selected from oxodiazolyl, oxazolyl, thiadiazolyl, and thiazolyl; X means N or CH; and each solubilizing group is independently selected from Structure (a), whereinе L is selected from N, M is selected from -О- and -S- and R is С1-С10alkyl; provided that B is a thiazolyl, and is not an imidazolyl or triazolyl.EFFECT: compounds of the invention are intended for treatment of hematological and/or proliferative disorders.(I),(а)11 cl, 4 tbl |